Praxis Precision Medicines is based in Bedminster. It has raised $100M in total funding. Latest round: Seed.
Praxis Precision Medicines funding overview
Praxis Precision Medicines is based in Bedminster. Praxis Precision Medicines has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed. Investors on record include Blackstone Life Sciences, Novo Holdings, Vida Ventures, Eventide. 4 distinct backers are named across the disclosed rounds.
Praxis Precision Medicines at a glance
Total raised
$100M
Latest round
Seed
Headquarters
Bedminster
Notable investors
Blackstone Life Sciences, Novo Holdings, Vida Ventures, Eventide
Frequently asked about Praxis Precision Medicines funding
How much has Praxis Precision Medicines raised?
Praxis Precision Medicines has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Praxis Precision Medicines?
Blackstone Life Sciences, Novo Holdings, Vida Ventures, Eventide are named among the investors backing Praxis Precision Medicines.
What was the latest Praxis Precision Medicines funding round?
The most recent disclosed round is a Seed.
Where is Praxis Precision Medicines based?
Praxis Precision Medicines is based in Bedminster.
Praxis Precision Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Bedminster below to benchmark round size and investor mix.
Companies related to Praxis Precision Medicines (37)
